secwatch.observer — SEC 8-K summary
======================================

Issuer:     CoreCivic, Inc. (CXW)
CIK:        0001070985
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001193125-26-208929
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CoreCivic Q1 revenue $614.7M (+25.8%), adjusted EPS $0.40, acquires Clinical Solutions Pharmacy for ~$148M
--------------------------------------------------------------------------------

- Revenue $614.7M, up 25.8% YoY; net income $37.9M ($0.38 diluted EPS) vs $25.1M ($0.23) YoY.
- Adjusted diluted EPS $0.40, up 73.9% YoY; Adjusted EBITDA $110.1M, up 36.0%.
- Acquired Clinical Solutions Pharmacy for ~$148M (cash + revolver); expected to contribute $0.03-$0.05/share in 2026.
- Increased full-year 2026 guidance: Adj. diluted EPS $1.53-$1.63 (from $1.49-$1.59); Adj. EBITDA $453.8M-$461.8M.
- Repurchased 2.3M shares for $44.7M in Q1; net debt/Adj. EBITDA 2.8x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070985/000119312526208929/0001193125-26-208929-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070985/000119312526208929/d302982d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-208929

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer